Baby Powder Talc Lawsuit: J&J Verdicts and AG Settlement

The baby powder talc lawsuit is a mass tort in which more than 90,000 people have sued Johnson & Johnson, alleging that its talc-based Johnson’s Baby Powder and Shower to Shower products were contaminated with asbestos and caused ovarian cancer or mesothelioma. After three failed attempts by J&J to resolve the claims through bankruptcy, cases are now moving forward individually in state and federal courts, and as of early 2026 the multidistrict litigation in New Jersey holds at least 67,623 pending claims, making it the largest active MDL in the country.1Sokolove Law. Johnson & Johnson Talcum Powder Lawsuits

What the Lawsuits Allege

Plaintiffs claim they developed cancer after years of using Johnson’s Baby Powder and similar talc products, and that J&J knew for decades the talc could contain asbestos. Two diseases dominate the docket. Mesothelioma, a cancer of the lining of the lung or abdomen, is widely accepted as caused by asbestos exposure. Ovarian cancer is the other major claim, and it is more contested scientifically.

Much of the talc at issue came from mines in Windsor County, Vermont, which J&J acquired in 1965 and owned through a subsidiary called Windsor Minerals until 1989. Until 2003, the majority of the talc used in Johnson’s Baby Powder came from those Vermont mines.2VTDigger. Vermont Talc at Center of Contaminated Baby Powder Case Geological analyses have confirmed that the Vermont mine contained fibrous talc and accessory tremolite-actinolite, both associated with asbestos contamination.3National Center for Biotechnology Information. Exposing an Unseen Hazard Internal company documents cited in a 2018 lawsuit indicated J&J and its supplier Imerys were aware the talc contained asbestos.4Mesothelioma.com. Imerys Talc Asbestos Exposure Former FDA Commissioner David Kessler testified in May 2026 that J&J executives had characterized the FDA’s proposal for independent talc testing as a “disturbing proposal,” and he alleged the company misled the agency for more than 50 years.1Sokolove Law. Johnson & Johnson Talcum Powder Lawsuits

What the Science Shows

Independent testing has repeatedly found asbestos in consumer talc. A 1976 study tested 20 retail talc products and found half contained tremolite and anthophyllite, both forms of asbestos. More recent independent testing of over 50 containers of a specific brand found asbestos fibers in every sample, at concentrations ranging from roughly 1,800 to over one million fibers per gram. Laboratory simulations have confirmed that applying talcum powder releases inhalable asbestos fibers into the air around the user and bystanders.5National Center for Biotechnology Information. Asbestos Content of Cosmetic Talcum Products

The ovarian cancer link is where the scientific fight is sharpest. In July 2024, the International Agency for Research on Cancer reclassified talc from “possibly carcinogenic” (Group 2B) to “probably carcinogenic” (Group 2A), citing limited evidence in humans, sufficient evidence in animals, and strong mechanistic evidence from laboratory experiments.6IARC. IARC Monographs Volume 136: Talc and Acrylonitrile Some epidemiologists have pushed back, noting the human evidence relies heavily on case-control studies susceptible to recall bias and that the reclassification is a hazard assessment rather than a real-world risk estimate.7Science Media Centre. Expert Reaction to IARC Monographs Evaluating the Carcinogenicity of Talc A separate 2024 systematic review of 77 studies concluded that existing epidemiological evidence does not support a causal association between talc exposure and any human cancer, though it acknowledged the consistent ovarian cancer signal in case-control research.8Taylor & Francis Online. A Systematic Review of the Epidemiology Evidence on Talc and Cancer

That dispute matters for trial strategy. In January 2026, a special master in the New Jersey MDL ruled that plaintiffs’ experts may testify about the link between talc and ovarian cancer, clearing the way for jury trials on those claims.9Sokolove Law. Talcum Powder Lawsuit Updates

Major Verdicts Against Johnson & Johnson

Juries have handed down some of the largest damage awards in mass tort history. The most prominent early case was the 2018 Missouri trial Ingham v. Johnson & Johnson, brought by 22 women with ovarian cancer. The jury awarded $550 million in compensatory damages and $4.14 billion in punitive damages, for a total of roughly $4.69 billion.10St. Louis Public Radio. Johnson & Johnson Hit With $4.69 Billion Loss in Baby Powder Ovarian Cancer Case A Missouri appeals court later reduced the punitive damages to $2.1 billion, and in June 2021 the U.S. Supreme Court declined to hear J&J’s challenge.11Washington Legal Foundation. Ingham v. Johnson & Johnson

More recent verdicts include:

  • A Baltimore jury awarded $1.5 billion in December 2025 to a 59-year-old woman with peritoneal mesothelioma, including $59.84 million in compensatory damages. J&J has said it will appeal.12Miller & Zois. Talcum Powder Lawsuit
  • A California jury awarded $966 million in October 2025 in the wrongful death case of Mae Moore, though a judge later struck the punitive damages and reduced the total to $16 million in March 2026.13Consumer Notice. Talcum Powder Settlements
  • An Oregon jury ordered J&J to pay $260 million in September 2024 to a mesothelioma patient, though a judge subsequently overturned the verdict.12Miller & Zois. Talcum Powder Lawsuit
  • A Massachusetts jury awarded $42.6 million in July 2025 to a mesothelioma patient and his spouse.12Miller & Zois. Talcum Powder Lawsuit
  • An Illinois jury awarded $45 million in April 2024 in the death of Theresa Garcia, finding J&J and its consumer health spinoff Kenvue liable and splitting fault 70/30.14Sokolove Law. Talcum Powder Settlements
  • A Minnesota mesothelioma patient, age 37, received $65.5 million.14Sokolove Law. Talcum Powder Settlements

The reductions and reversals matter. A headline verdict is not always the amount ultimately paid.

Why There Is No Global Settlement

J&J tried three times to resolve the entire litigation through a subsidiary bankruptcy using a maneuver called the Texas two-step. Twice, in 2021 and 2023, it created a subsidiary called LTL Management, loaded it with the talc liabilities, and filed for Chapter 11. Both were dismissed by the Third Circuit Court of Appeals.15Bailey Glasser. In Re Red River Talc LLC Memorandum Decision and Order

The third attempt, through a subsidiary called Red River Talc LLC, proposed a $9 billion settlement trust. On March 31, 2025, U.S. Bankruptcy Judge Christopher Lopez denied confirmation and dismissed the case. The court found the plan contained impermissible nonconsensual releases of non-debtor parties like J&J and Kenvue, applying the Supreme Court’s 2024 ruling in Harrington v. Purdue Pharma, which held that bankruptcy courts cannot release non-debtor entities from liability without affected claimants’ consent. Judge Lopez also found that plaintiffs’ firms had voted on behalf of tens of thousands of clients without proper authority and that thousands of claimants had been given an unreasonably short window to cast ballots.16Cadwalader. J&J’s Failed Third Try Casts Doubt on Use of Texas Two-Step

J&J said it would not appeal and would fight cases individually in court.1Sokolove Law. Johnson & Johnson Talcum Powder Lawsuits The talc suppliers took a different path: Imerys Talc America and its affiliates filed Chapter 11 in Delaware on February 13, 2019, and Cyprus Mines Corporation followed on February 11, 2021. In early 2024, the two companies proposed a collective $862 million asbestos trust fund to resolve current and future personal injury claims.17Asbestos.com. Talc Companies Create Asbestos Trust Confirmation of the Imerys plan was still pending as of March 2026.18KPMG. Tenth Report of the Information Officer

The State Attorneys General Settlement and Product Withdrawal

In June 2024, J&J agreed to pay $700 million to 42 state attorneys general and the District of Columbia to resolve allegations that the company deceptively marketed its talc-based baby and body powder despite knowing the products could be contaminated with asbestos. The coalition alleged J&J misled consumers about product safety and targeted marketing at communities of color.19New York Attorney General. Attorney General James Helps Secure $700 Million From Johnson & Johnson Under the deal, J&J is permanently barred from manufacturing, selling, or distributing any talc-containing powder products in the United States.20New Jersey Attorney General. Attorney General Platkin, 42 States Announce $700 Million Johnson & Johnson Settlement That money went to the states, not to individual consumers with cancer diagnoses, whose claims remain in the personal injury litigation.

J&J had already pulled talc-based baby powder from the U.S. and Canadian markets in May 2020, citing declining demand driven by what it called “misinformation” and litigation advertising.21Johnson & Johnson. Johnson & Johnson Consumer Health Announces Discontinuation of Talc-Based Johnsons Baby Powder in U.S. and Canada In August 2022, the company said it would end global sales in 2023 and switch entirely to a cornstarch-based formula, describing the move as a commercial decision and continuing to maintain that its talc products were safe.22BBC. Johnson & Johnson to End Talc-Based Baby Powder Sales Globally

Where Things Stand for Claimants Now

With the bankruptcy route closed, cases are moving through the courts individually. Roughly 95% of mesothelioma claims have been resolved through out-of-court settlements, but thousands of ovarian cancer cases remain unresolved, and there is no global settlement for them.1Sokolove Law. Johnson & Johnson Talcum Powder Lawsuits The January 2026 ruling allowing plaintiffs’ experts to testify on the ovarian cancer link is expected to accelerate individual trials through 2026 and beyond. Anyone considering a claim should be aware that state-level product liability deadlines vary and that eligibility typically turns on documented product use and a qualifying cancer diagnosis; specifics are handled by counsel on a case-by-case basis.